Skip to content

Released Aug 5, 2021, after the close

10-Q filed Aug 6, 2021, 37 days after period end · 0001636422-21-000068

Q2 2021 · 10-Q
Revenue$59.63M+37.8% vs Q2 2020+6.8% vs Q1 2021
Net Income-$35.83MN/M vs Q2 2020N/M vs Q1 2021
EPS Diluted-$0.80N/M vs Q2 2020N/M vs Q1 2021
Operating Income-$32,319,000N/M
Operating Cash Flowderived-$4,845,000N/M
Free Cash Flowderived-$7,101,000N/M
Margins · derived
Operating margin-54.2%−18.0 pt vs Q2 2020
Net margin-60.1%+2.7 pt vs Q2 2020

What the release said

The release

Same quarter

MetricQ2 2021Q2 2020Q2 2019Q2 2018
Revenue$59.63M$43.26M$36.80M$22.99M
Net Income-$35.83M-$27.18M-$10.69M-$19.32M
EPS Diluted-$0.80-$0.71-$21.98-$3.53

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR